Grant Pickering
Founder at VAXCYTE, INC.
Net worth: 53 M $ as of 2024-03-30
Profile
Grant E.
Pickering is the founder of Vaxcyte, Inc. (founded in 2013) where he holds the title of Chief Executive Officer & Director.
He is currently working as an Independent Director at Athira Pharma, Inc. since 2022.
Mr. Pickering's former positions include being the President, Chief Executive Officer & Director at Mymetics Corp.
in 2012, President, Chief Executive Officer & Director at Juvaris BioTherapeutics, Inc., and Senior Vice President-Operations at Dendreon Corp.
Mr. Pickering completed his undergraduate degree at The Pennsylvania State University in 1989 and obtained an MBA from Georgetown University in 1997.
Known holdings in public companies
| Company | Date | Number of shares | Valuation | Valuation date |
|---|---|---|---|---|
VAXCYTE, INC.
0.71% | 2024-04-22 | 772,571 ( 0.71% ) | 53 M $ | 2024-03-30 |
ATHIRA PHARMA, INC.
0.07% | 2023-05-18 | 25,783 ( 0.07% ) | 70 645 $ | 2024-03-30 |
Grant Pickering active positions
| Companies | Position | Start |
|---|---|---|
| VAXCYTE, INC. | Founder | 2013-05-26 |
| ATHIRA PHARMA, INC. | Director/Board Member | 2022-01-26 |
Former positions of Grant Pickering
| Companies | Position | End |
|---|---|---|
| MYMETICS CORPORATION | Chief Executive Officer | 2012-11-18 |
| DENDREON CORPORATION | Chief Operating Officer | 2005-11-17 |
Juvaris BioTherapeutics, Inc.
 Juvaris BioTherapeutics, Inc. BiotechnologyHealth Technology Juvaris BioTherapeutics, Inc. develops novel, adjuvanted vaccines and immunotherapeutics to treat infectious disease and cancer. The company was founded by Martin D. Cleary, Jeff Fairman and Steven W. Dow in February 2003 and is headquartered in Burlingame, CA. | Chief Executive Officer | - |
Training of Grant Pickering
| The Pennsylvania State University | Undergraduate Degree |
| Georgetown University | Masters Business Admin |
Experiences
Positions held
Connections
1st degree connections
1st degree companies
Male
Female
Members of the board
Executives
Linked companies
| Listed companies | 3 |
|---|---|
| MYMETICS CORPORATION | Health Technology |
| ATHIRA PHARMA, INC. | Health Technology |
| VAXCYTE, INC. | Health Technology |
| Private companies | 2 |
|---|---|
Dendreon Corp.
 Dendreon Corp. Medical SpecialtiesHealth Technology Dendreon Corp. discovers, develops and commercializes novel products for the treatment of cancer. The company applies its expertise in antigen identification, engineering and cell processing to produce active cellular immunotherapy ACI product candidates designed to stimulate an immune response in a variety of tumor types. It is an exploring the application of additional ACI product candidates and small molecules for the potential treatment of a variety of cancers. Dendreon was founded by Christopher S. Henney, Edgar G. Engleman and Samuel Strober in 1992 and is headquartered in Seattle, WA. | Health Technology |
Juvaris BioTherapeutics, Inc.
Juvaris BioTherapeutics, Inc. BiotechnologyHealth Technology Juvaris BioTherapeutics, Inc. develops novel, adjuvanted vaccines and immunotherapeutics to treat infectious disease and cancer. The company was founded by Martin D. Cleary, Jeff Fairman and Steven W. Dow in February 2003 and is headquartered in Burlingame, CA. | Health Technology |
- Stock Market
- Insiders
- Grant Pickering
